In the right population, hydroxychloroquine works. So why are people still up in arms?

Published



The debate over the use of hydroxychloroquine rages on as COVID-19 cases in the United States exceed 6,000,000 and deaths approach 200,000.

From many respected corners of the medical and regulatory establishment, we have been led to believe, emphatically, that the case for HCQ is now closed. Many studies are cited as evidence that giving HCQ to COVID-19 patients is, at best, ineffective and, at worst, harmful.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.